168 related articles for article (PubMed ID: 34762514)
1. Tumour-to-normal tissue (T/N) dosimetry ratios role in assessment of
Knešaurek K; Martinez RB; Ghesani M
Br J Radiol; 2022 Jan; 95(1129):20210294. PubMed ID: 34762514
[TBL] [Abstract][Full Text] [Related]
2. Comparison of perfused volume segmentation between cone-beam CT and
Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB
Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960
[TBL] [Abstract][Full Text] [Related]
3. Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept.
Garin E; Lenoir L; Edeline J; Laffont S; Mesbah H; Porée P; Sulpice L; Boudjema K; Mesbah M; Guillygomarc'h A; Quehen E; Pracht M; Raoul JL; Clement B; Rolland Y; Boucher E
Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1057-68. PubMed ID: 23613103
[TBL] [Abstract][Full Text] [Related]
4. PET-CT post therapy dosimetry in radioembolization with resin
Richetta E; Pasquino M; Poli M; Cutaia C; Valero C; Tabone M; Paradisi BP; Pacilio M; Pellerito RE; Stasi M
Phys Med; 2019 Aug; 64():16-23. PubMed ID: 31515015
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Carcinoma Tumor Dose Response After
Kappadath SC; Mikell J; Balagopal A; Baladandayuthapani V; Kaseb A; Mahvash A
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):451-461. PubMed ID: 30191875
[TBL] [Abstract][Full Text] [Related]
6. High quality imaging and dosimetry for yttrium-90 (
Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618
[TBL] [Abstract][Full Text] [Related]
7. An estimate of
Knešaurek K
Eur J Radiol; 2021 Jun; 139():109698. PubMed ID: 33848778
[TBL] [Abstract][Full Text] [Related]
8. 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates.
Brosch J; Gosewisch A; Kaiser L; Seidensticker M; Ricke J; Zellmer J; Bartenstein P; Ziegler S; Ilhan H; Todica A; Böning G
Phys Med; 2020 Dec; 80():317-326. PubMed ID: 33248338
[TBL] [Abstract][Full Text] [Related]
9. Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.
Gnesin S; Canetti L; Adib S; Cherbuin N; Silva Monteiro M; Bize P; Denys A; Prior JO; Baechler S; Boubaker A
J Nucl Med; 2016 Nov; 57(11):1672-1678. PubMed ID: 27307346
[TBL] [Abstract][Full Text] [Related]
10. Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma.
Allimant C; Kafrouni M; Delicque J; Ilonca D; Cassinotto C; Assenat E; Ursic-Bedoya J; Pageaux GP; Mariano-Goulart D; Aho S; Guiu B
J Vasc Interv Radiol; 2018 Dec; 29(12):1662-1670.e4. PubMed ID: 30217745
[TBL] [Abstract][Full Text] [Related]
11. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
[TBL] [Abstract][Full Text] [Related]
12. Radioembolization with
Ho CL; Chen S; Cheung SK; Leung YL; Cheng KC; Wong KN; Wong YH; Leung TWT
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2110-2121. PubMed ID: 29948107
[TBL] [Abstract][Full Text] [Related]
13. Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with
Watanabe M; Grafe H; Theysohn J; Schaarschmidt B; Ludwig J; Jochheim L; Jeschke M; Schmidt H; Fendler WP; Moraitis A; Herrmann K; Pomykala KL; Weber M
J Nucl Med; 2023 Jul; 64(7):1102-1108. PubMed ID: 37290792
[TBL] [Abstract][Full Text] [Related]
14. A microscopic model of the dose distribution in hepatocellular carcinoma after selective internal radiation therapy.
Cutrì E; Morel-Corlu E; Rolland Y; Saint-Jalmes H; Eliat PA; Garin E; Bezy-Wendling J
Phys Med; 2024 Jun; 122():103384. PubMed ID: 38824827
[TBL] [Abstract][Full Text] [Related]
15. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
[TBL] [Abstract][Full Text] [Related]
16. Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models.
Mikell JK; Mahvash A; Siman W; Baladandayuthapani V; Mourtada F; Kappadath SC
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):888-896. PubMed ID: 27623307
[TBL] [Abstract][Full Text] [Related]
17. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
Song YS; Paeng JC; Kim HC; Chung JW; Cheon GJ; Chung JK; Lee DS; Kang KW
Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323
[TBL] [Abstract][Full Text] [Related]
18. Selective internal radiation therapy of hepatic tumors: Morphologic and functional imaging for voxel-based computer-aided dosimetry.
Skanjeti A; Magand N; Defez D; Tordo J; Rode A; Manichon AF; Hallouard F; Clave-Darcissac C; Dhomps A; Townsend DM; Rubello D; Giammarile F
Biomed Pharmacother; 2020 Dec; 132():110865. PubMed ID: 33254427
[TBL] [Abstract][Full Text] [Related]
19. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres.
Levillain H; Bagni O; Deroose CM; Dieudonné A; Gnesin S; Grosser OS; Kappadath SC; Kennedy A; Kokabi N; Liu DM; Madoff DC; Mahvash A; Martinez de la Cuesta A; Ng DCE; Paprottka PM; Pettinato C; Rodríguez-Fraile M; Salem R; Sangro B; Strigari L; Sze DY; de Wit van der Veen BJ; Flamen P
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1570-1584. PubMed ID: 33433699
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of imaging
Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM
Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]